Synthesis and Biological Evaluation of Substituted Pyrazole-Fused Oleanolic Acid Derivatives as Novel Selective α-Glucosidase Inhibitors

被引:5
作者
Gao, Mei [1 ,2 ]
Ma, Hui [2 ]
Liu, Xiaoyu [2 ]
Zhang, Yanhua [2 ]
Tang, Liansheng [2 ]
Zheng, Zhiyong [2 ]
Zhang, Xinlei [3 ]
Jiang, Chengshi [4 ]
Lin, Lin [2 ]
Sun, Haiji [1 ]
机构
[1] Shandong Normal Univ, Coll Life Sci, Shandong Prov Key Lab Anim Resistance Biol, Jinan 250014, Peoples R China
[2] Shandong Acad Pharmaceut Sci, Jinan 250101, Peoples R China
[3] Fourth Mil Med Univ, Sch Pharm, Dept Med Chem, Xian 710032, Shaanxi, Peoples R China
[4] Univ Jinan, Sch Biol Sci & Technol, Jinan 250022, Peoples R China
关键词
oleanolic acid; pyrazole derivatives; alpha-glucosidase inhibitor; alpha-amylase; molecular docking; TYPE-2; DIABETES-MELLITUS; THERAPY; MECHANISM;
D O I
10.1002/cbdv.202201178
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A series of novel substituted pyrazole-fused oleanolic acid derivative were synthesized and evaluated as selective alpha-glucosidase inhibitors. Among these analogs, compounds 4a-4f exhibited more potent inhibitory activities compared with their methyl ester derivatives, and standard drugs acarbose and miglitol as well. Besides, all these analogs exhibited good selectivity towards alpha-glucosidase over alpha-amylase. Analog 4d showed potent inhibitory activity against alpha-glucosidase (IC50=2.64 & PLUSMN;0.13 mu M), and greater selectivity towards alpha-glucosidase than alpha-amylase by & SIM;33-fold. Inhibition kinetics showed that compound 4d was a non-competitive alpha-glucosidase inhibitor, which was consistent with the result of its simulation molecular docking. Moreover, the in vitro cytotoxicity of compounds 4a-4f towards hepatic LO2 and HepG2 cells was tested.
引用
收藏
页数:9
相关论文
共 40 条
  • [1] In vitro inhibitory effects of plant-based foods and their combinations on intestinal α-glucosidase and pancreatic α-amylase
    Adisakwattana, Sirichai
    Ruengsamran, Thanyachanok
    Kampa, Patcharaporn
    Sompong, Weerachat
    [J]. BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2012, 12
  • [2] Atlas, 2019, IDF DIABETES ATLAS, DOI DOI 1124156/HTTPS://WWW.DIABETESATLAS.ORG/UPLOAD/RESOURCES/MATERIAL/20191218_144459_2019_GLOBAL_FACTSHEET.PDF
  • [3] Oleanolic Acid and Its Derivatives: Biological Activities and Therapeutic Potential in Chronic Diseases
    Ayeleso, Taiwo Betty
    Matumba, Mashudu Given
    Mukwevho, Emmanuel
    [J]. MOLECULES, 2017, 22 (11):
  • [4] Design, synthesis, biological evaluation, and molecular modeling studies of pyrazole-benzofuran hybrids as new α-glucosidase inhibitor
    Azimi, Fateme
    Azizian, Homa
    Najafi, Mohammad
    Khodarahmi, Ghadamali
    Saghaei, Lotfollah
    Hassanzadeh, Motahareh
    Ghasemi, Jahan B.
    Faramarzi, Mohammad Ali
    Larijani, Bagher
    Hassanzadeh, Farshid
    Mahdavi, Mohammad
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [5] Design and synthesis of novel quinazolinone-pyrazole derivatives as potential α-glucosidase inhibitors: Structure-activity relationship, molecular modeling and kinetic study
    Azimi, Fateme
    Azizian, Homa
    Najafi, Mohammad
    Hassanzadeh, Farshid
    Sadeghi-aliabadi, Hojjat
    Ghasemi, Jahan B.
    Faramarzi, Mohammad Ali
    Mojtabavi, Somayeh
    Larijani, Bagher
    Saghaei, Lotfollah
    Mahdavi, Mohammad
    [J]. BIOORGANIC CHEMISTRY, 2021, 114
  • [6] BISCHOFF H, 1995, CLIN INVEST MED, V18, P303
  • [7] Water fraction of edible medicinal fern Stenochlaena palustris is a potent α-glucosidase inhibitor with concurrent antioxidant activity
    Chai, Tsun-Thai
    Kwek, Meng-Tee
    Ong, Hean-Chooi
    Wong, Fai-Chu
    [J]. FOOD CHEMISTRY, 2015, 186 : 26 - 31
  • [8] Synthesis and bioactivities evaluation of oleanolic acid oxime ester derivatives as α-glucosidase and α-amylase inhibitors
    Deng, Xu-Yang
    Ke, Jun-Jie
    Zheng, Ying-Ying
    Li, Dong-Li
    Zhang, Kun
    Zheng, Xi
    Wu, Jing-Ying
    Xiong, Zhuang
    Wu, Pan-Pan
    Xu, Xue-Tao
    [J]. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2022, 37 (01) : 451 - 461
  • [9] Current Medicinal Chemistry
    Devaraj, Surabhi
    Yip, Yew Mun
    Panda, Parthasarathi
    Ong, Li Lin
    Wong, Pooi Wen Kathy
    Zhang, Dawei
    Ali, Yusuf
    Judeh, Zaher
    [J]. CURRENT MEDICINAL CHEMISTRY, 2022, 29 (09) : 1606 - 1621
  • [10] Synthetic heterocyclic candidates as promising α-glucosidase inhibitors: An overview
    Dhameja, Manoj
    Gupta, Preeti
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 176 : 343 - 377